Simultaneous Investigation: Streptococcus pyogenes and Molecular COVID‐19 Testing in Corona Suspected Cases

Background The relationship between Streptococcus pyogenes (Group A Streptococcus) and COVID‐19 has been of interest because of possible coinfections and their clinical implications. This discussion examines the interaction between these pathogens and focuses on rates of coinfection, effects, and diagnostic considerations. Materials and Methods This study on 119 COVID‐19 patients involved sampling pharyngeal and nasal secretions for streptococcal culture and PCR testing. RNA extraction, cDNA synthesis, and RT‐qPCR targeted the N gene of SARS‐CoV‐2. Results This study on 119 COVID‐19 patients revealed a prevalence of 52.94%, with higher rates among women and older individuals. Streptococcal infection prevalence was 34.45%, significantly elevated in COVID‐19 patients compared with noninfected individuals ( p < 0.001). Notably, streptococcal infection rates were higher in men, older age groups, and those exhibiting symptoms like shortness of breath, cough, fever, weakness, and lethargy ( p < 0.001). Conclusion The co‐occurrence of S . pyogenes infections with COVID‐19 complicates diagnosis, necessitating comprehensive laboratory testing. Understanding their epidemiology informs public health strategies for surveillance, prevention, and control, highlighting the complexities in infectious disease management.